Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Revenues		$ 16,146
Costs and operating expenses:
Cost of revenues		475
Research and development	$ 17,044	13,029
General and administrative	5,870	8,247
Total costs and operating expenses	22,914	21,751
Loss from operations	(22,914)	(5,605)
Other income, net:
Interest and investment income	1,241	1,550
Sublease income	515	799
Total other income, net	1,756	2,349
Net loss	$ (21,158)	$ (3,256)
Net loss per common share - basic	$ (0.35)	$ (0.06)
Net loss per common share - diluted	$ (0.35)	$ (0.06)
Weighted average shares of common stock outstanding - basic	61,048,948	51,289,284
Weighted average shares of common stock outstanding - diluted	61,048,948	51,289,284
Other comprehensive loss:
Net unrealized loss on marketable debt securities	$ (121)	$ (123)
Other comprehensive loss	(121)	(123)
Comprehensive loss	$ (21,279)	(3,379)
Royalty Revenues
Revenues		8,146
Sale of Royalty Rights
Revenues		$ 8,000